| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/12/2004 | US20040029128 Analyzing methylation patterns; cell proliferation; cancer diagnosis |
| 02/12/2004 | US20040029124 Generation hybrid Dna using primers and ligase; analyzing gene expression patterns |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040029122 Using mitochrondria Dna sequences; diabetes diagnosis |
| 02/12/2004 | US20040029121 Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene |
| 02/12/2004 | US20040029120 Method of non-targeted complex sample analysis |
| 02/12/2004 | US20040029119 Hybridizing using oligonucleotide probe and monitoring the signal intensity; fluorometry |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 02/12/2004 | US20040029114 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 02/12/2004 | US20040029113 Cleaving single-stranded nucleic acid sequences by contacting with a oligonucleotide; restriction endonuclease recognition site; fab fragments |
| 02/12/2004 | US20040029112 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/12/2004 | US20040029111 Capture oligonucleotide comprising a polynucleotide with a complementary sequence; kits; useful in determining very low levels of nucleic acids |
| 02/12/2004 | US20040029110 Hepatitis B virus (HBV); releasing, isolating or concentrating the polynucleic acids; amplification; hybridization to a mutant target sequence such as pol gene region |
| 02/12/2004 | US20040029108 Immobilization onto coated surface; presence of microforce is measured by deflection of the apparatus |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040029105 Detection of variola virus |
| 02/12/2004 | US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | US20040028672 Calibration of infection therapy measuring proteinase; antiulcer agents; wound healing agent |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028664 Archiving of vectors |
| 02/12/2004 | US20040028620 Separation of living particles from a gas under pressure |
| 02/12/2004 | US20040028608 Hygiene monitoring |
| 02/12/2004 | US20040028607 Polypeptides; antiproliferative agent |
| 02/12/2004 | US20040028567 High throughput screening assay systems in microscale fluidic devices |
| 02/12/2004 | US20040026266 Quantitative analysis; redox systems; electrolytic cells, filter, interface and charge transfer compound |
| 02/12/2004 | US20040026244 Antioxidant sensor |
| 02/12/2004 | US20040026243 Continuous process for manufacture of disposable electro-chemical sensor |
| 02/12/2004 | DE4429660B4 Zusatzmittel für diagnostische Tests zur Bestimmung der Gerinnungsfähigkeit des Blutes, Verfahren zur Reduzierung der Beeinflussung von diagnostischen Tests durch Heparin und Verwendung von Metallsalzen zu diesen Zwecken Admixtures for diagnostic tests for determining the clotting ability of the blood, methods for reducing the influencing of diagnostic tests by heparin and use of metal salts for this purpose |
| 02/12/2004 | DE20316651U1 Analyse und Verwaltung molekularer Daten und Sequenzen Analysis and management of molecular data and sequences |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10235310A1 Determining the allergenic potency of products, useful e.g. for diagnosis, comprises measuring changes in intracellular calcium of isolated granulocytes or mast cells |
| 02/12/2004 | DE10234564A1 Biosensor Biosensor |
| 02/12/2004 | DE10234524A1 Array of probes derived from monocyte-macrophage genes, useful e.g. for diagnosis, prognosis and therapeutic monitoring of rheumatoid arthritis and other inflammatory diseases |
| 02/12/2004 | DE10234418A1 Verfahren zur Untersuchung und Beurteilung von Virusenzymen im HTS Method for the assessment of viral enzymes in the HTS |
| 02/12/2004 | DE10233970A1 Multi-well filtration plate, for high throughput applications in the automatic isolation of DNA and RNA, has a nonwoven support at the filter membrane to stabilize it and prevent damage |
| 02/12/2004 | DE10233686A1 Determining hydrolase activity, useful especially for detecting nitrilase and amidase, by reaction with acid derivative and hydroxylamine, then with ferric iron solution |
| 02/12/2004 | DE10233676A1 New polypeptide allergens from fungi, useful in desensitizing vaccines and for diagnosis, also related nucleic acids, vectors and transformed cells |
| 02/12/2004 | DE10233516A1 Cellular method for identifying modulators of target molecules, useful in screening for pharmaceuticals, from effects of test compounds on both cell growth and reporter expression |
| 02/12/2004 | DE10232775A1 Kit for detection of microorganisms on skin, useful e.g. for diagnosis of infection, comprises specific oligonucleotides for in situ hybridization |
| 02/12/2004 | DE10231435A1 Nachweisverfahren zur Prüfung der Originalität eines Objekts Detection methods for checking the originality of an object |
| 02/12/2004 | DE10230692A1 Verfahren und Nukleinsäuren für die Analyse von Methylierungsmustern innerhalb des DD3-Gens Methods and nucleic acids for the analysis of methylation patterns within the DD3 gene |
| 02/12/2004 | DE10112515B4 Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität A method for detecting cytosine methylation patterns with high sensitivity |
| 02/12/2004 | CA2523011A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | CA2497570A1 Methods and compositions for genotyping |
| 02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | CA2494837A1 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494577A1 Mk2 interacting proteins |
| 02/12/2004 | CA2494478A1 Fluorescence correlation spectroscopy instrument |
| 02/12/2004 | CA2494356A1 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 02/12/2004 | CA2494240A1 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2494073A1 Fluorescence polarization assay |
| 02/12/2004 | CA2494033A1 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays |
| 02/12/2004 | CA2493993A1 Method of measuring molecular interactions |
| 02/12/2004 | CA2493817A1 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | CA2493791A1 Large circular sense molecule array |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493745A1 Method and device for protein delivery into cells |
| 02/12/2004 | CA2493532A1 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/11/2004 | EP1388735A1 Reagent for assaying lipids |
| 02/11/2004 | EP1388734A1 Method for solution based diagnosis |
| 02/11/2004 | EP1388590A2 Gene assay method for predicting glaucoma onset risk |
| 02/11/2004 | EP1388589A1 Genetic polymorphisms sensitively predicting adverse drug reaction (ADR) and drug efficacy |
| 02/11/2004 | EP1388587A1 Biomolecular substrate and method and apparatus for examination and diagnosis using the same |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1388007A1 Method for qualitative and/or quantitative determination of gender, species, race and/or geographical origin of biological materials |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387894A1 Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization |
| 02/11/2004 | EP1387893A1 An assay for detecting inhibitors of the enzyme mueloperokidase |
| 02/11/2004 | EP1387890A2 Peptidylarginine deiminase 6 |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387887A2 Quantitative epstein barr virus pcr rapid assay |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387855A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 02/11/2004 | EP1387853A2 Method for producing and identifying appropriate effectors of target molecules using substance libraries |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1230380B1 Enzyme substrates and assay involving intramolecular fret |
| 02/11/2004 | EP1144692B1 Method for separating nucleic acids into populations |
| 02/11/2004 | EP1104492B1 Subtle mitochondrial mutations as tumor markers |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0918881B1 Dry reagent test strip comprising benzidine dye precursor and antipyrine compound |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | CN2603391Y Typographic compound microarray |
| 02/11/2004 | CN1474944A Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 02/11/2004 | CN1474943A Supports for hybridization and method of immobilizing hybrid |
| 02/11/2004 | CN1474875A Map-based genome mining method for identifying regulatory loci controlling level of gene transcripts and products |
| 02/11/2004 | CN1474872A Method for modifying plant morphology, biochemistry and physiology |
| 02/11/2004 | CN1474870A Method of Synthesizing polynucleotide |
| 02/11/2004 | CN1473944A Gene Polymorphism detection method based on DNA adaptor |
| 02/11/2004 | CN1473943A Multiple PCR primer group for human HNF-1 alpha gene amplification |
| 02/11/2004 | CN1473942A Gene chip technology based on labeled primer hybridization |
| 02/11/2004 | CN1473941A Gene chip technology based on end deoxyribonucleic acid transferase |
| 02/11/2004 | CN1473940A Limited fluorescence labelling method |